Disrupting

Current global spinal devices market estimated at $10.2 bn per annum and is expected to grow at a CAGR of 3.1% through 2026

Helping

1.62 million instrumented spinal procedures are carried out each year and North America currently accounts for approximately 54% of these

Transforming

Healthcare and indirect costs due to back pain are over $US12 billion per year

Management Team

TruSpine has a highly experienced management team with a background in medical device manufacture, sales, distribution and marketing in addition to market disruption and taking products from an idea to a successful commercialisation.

Medical Advisory Board

The medical advisory board has been assembled to complement the Company’s full time board and management team. It consists of highly qualified spinal surgeons and doctors from leading academic and medical institutions in Europe and the United States.

Market Growth

The market is expected to grow at a CAGR of 3.1% through 2026 primarily due to:

  • Emerging markets
  • Ageing global populations
  • Increase in obesity
  • Increasing awareness of treatment options